Berkeley HeartLab, Inc

Berkeley HeartLab a Celera Business, enables personalized patient care. Berkeley HeartLab provides cardiovascular disease (CVD) management tools and services with a distinctive focus on the secondary prevention market. Unlike other lipid testing companies that are focused on the primary screening market for CVD, our proprietary testing technology enables risk characterization and uniquely allows for ongoing therapeutic monitoring of a patients disease. The Berkeley HeartLab high complexity CLIA-certified laboratory provides over 35 clinical diagnostic tests. Our comprehensive approach includes assays that determine lipoprotein particle size and density based on our proprietary segmented gradient gel electrophoresis technology and state-of-the-art genetic testing. These...

Berkeley heartlab, inc operates in the Biotechnology research industry.

Berkeley heartlab, inc's revenue is 11m - 100m

Berkeley heartlab, inc has 51 - 200 employees.